Alexandra Chisholm | Mount Sinai

About Me

Currently, I work as a postdoctoral fellow at the Icahn School of Medicine at Mount Sinai under the supervision Dr. Yasmin Hurd where I am investigating the neural mechanisms by which cannabidiol (CBD) reduces relapse to opiates. I utilize a multi-pronged approach combining in vivo region specific and cell type specific projection imaging with RNA (bulk and single cell) combined with ATAC sequencing to characterize the molecular transcriptome and epigenome associated with opioid relapse prior to and following treatment with cannabidiol.

Language

English

Position

POSTDOCTORAL FELLOW | Psychiatry

Research Topics

Addiction, Brain, Computational Neuroscience, Epigenetics, Neurobiology, Neurotransmitters, Opioid/Cannabinoid Receptors, Proteomics, RNA, Synaptic Plasticity, Translational Research

Education

PhD, Concordia University

Awards

2021

FRQNT Postdoctoral Fellowship

Fonds de recherche du Québec – Nature et technologies (FRQNT)

2017

NSERC Doctoral Scholarship (PGS-D)

Natural Sciences and Engineering Research Council of Canada

2015

NSERC Master's Scholarship (CGS-M)

Natural Sciences and Engineering Research Council of Canada

Research

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. CHISHOLM has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.